ArticleRSC advances2026

Quinazolinone-diarylpyrazole hybrids as dual EGFR/COX-2 inhibitors: antiproliferative, mechanistic, and

Abdullah Alkhammash et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.